Search research articles
Contact Us
Filters
Showing results (161-170 of 173) with videos related to
Page
of 18
Sort By:
British Journal of Pharmacology
|
September 8, 2011
Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3
Belinda Nedjai, Hubert Li, Ilana L Stroke, et al.
Nature Communications
|
July 7, 2019
Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7
Breanne L Harty, Fernanda Coelho, Sarah E Pease-Raissi, et al.
Molecular Pharmacology
|
March 20, 2009
Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5
Spencer E Hall, Allen Mao, Vicky Nicolaidou, et al.
British Journal of Haematology
|
February 14, 2002
Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease
Mark T Gladwin, James H Shelhamer, Frederick P Ognibene, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 9, 2008
Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection
Shulin Qin, Yongjun Sui, Adam C Soloff, et al.
The Journal of Clinical Investigation
|
October 8, 1999
Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity
M T Gladwin, A N Schechter, J H Shelhamer, et al.
Science Immunology
|
June 9, 2019
Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans
Franz Puttur, Laura Denney, Lisa G Gregory, et al.
Investigative Ophthalmology & Visual Science
|
April 28, 2004
Increased expression of iron-regulating genes in monkey and human glaucoma
Ronald H Farkas, Itay Chowers, Abigail S Hackam, et al.
The Journal of Biological Chemistry
|
July 14, 2006
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation
Nagarajan Vaidehi, Sabine Schlyer, Rene J Trabanino, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 14, 2008
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors
Dennis Verzijl, Stefania Storelli, Danny J Scholten, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 173) with videos related to
Sort By:
Page
of 18
British Journal of Pharmacology
|
September 8, 2011
Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3
Belinda Nedjai, Hubert Li, Ilana L Stroke, et al.
Nature Communications
|
July 7, 2019
Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7
Breanne L Harty, Fernanda Coelho, Sarah E Pease-Raissi, et al.
Molecular Pharmacology
|
March 20, 2009
Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5
Spencer E Hall, Allen Mao, Vicky Nicolaidou, et al.
British Journal of Haematology
|
February 14, 2002
Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease
Mark T Gladwin, James H Shelhamer, Frederick P Ognibene, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 9, 2008
Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection
Shulin Qin, Yongjun Sui, Adam C Soloff, et al.
The Journal of Clinical Investigation
|
October 8, 1999
Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity
M T Gladwin, A N Schechter, J H Shelhamer, et al.
Science Immunology
|
June 9, 2019
Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans
Franz Puttur, Laura Denney, Lisa G Gregory, et al.
Investigative Ophthalmology & Visual Science
|
April 28, 2004
Increased expression of iron-regulating genes in monkey and human glaucoma
Ronald H Farkas, Itay Chowers, Abigail S Hackam, et al.
The Journal of Biological Chemistry
|
July 14, 2006
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation
Nagarajan Vaidehi, Sabine Schlyer, Rene J Trabanino, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 14, 2008
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors
Dennis Verzijl, Stefania Storelli, Danny J Scholten, et al.
Page
of 18